Funding search · EIN 953772528 · Irvine, CA

Pediatric Cancer Research Foundation

Name: Pediatric Cancer Research Foundation grants, 2022–2024
Creator: PaperOrbit
License: https://www.irs.gov/charities-non-profits/exempt-organization-public-disclosure-and-availability-requirements

A grantmaking public charity (files IRS Form 990, Schedule I). Charities like this often run real grant programs with application cycles.

60
grants reported: $5.9M
total given: 2022–2024
filing years: $50,000
median grant

Based on grants this organization reported to the IRS for tax years 2022–2024. This is what they filed, not a complete record of their giving, and recent years may be incomplete because filings lag.

What they fund

pediatric cancer cell high patients research targeting care

Funder website ↗Full IRS filings ↗How this is built Report an error

Funding pattern

What this funder pays for, at what size, and how to position adjacent work. Read from their filings, with every number checked against the record.

7 grants matching “immunotherapies” · $354,700

$37,500
Case Western · Clevenland, OH · 2024
Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors
$37,500
Case Western · Clevenland, OH · 2024
Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors
$75,000
Case Western · Clevenland, OH · 2023
Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors
$75,000
Baylor College of Medicine · Houston, TX · 2023
Off-the-shelf combination cancer immunotherapy with oncolytic adeno-immunotherapy and car nk cell therapy for pediatric sarcoma
$75,000
Baylor College of Medicine · Houston, TX · 2022
Off-the-shelf combination cancer immunotherapy with oncolytic adeno-immunotherapy and car nk cell therapy for pediatric sarcoma
$29,700
Massachusetts General Hospital · Boston, MA · 2022
Optimizing car t cell immunotherapy for pediatric rhabdomyosarcoma
$25,000
Ann & Robert Lurie Children'S Hospital · Chicago, IL · 2022
Immunotherapy for dipg

Top recipients

Repeat recipients are the strongest signal of whether a funder has an open door or quietly re-funds the same organizations.

New York Medical College4 grants · $2.3M
Memorial Sloan Kettering3 grants · $375,000
Dana Farber3 grants · $255,000
Stanford University3 grants · $240,000
V Foundation1 grant · $204,000
City of Hope4 grants · $200,000
University of California San Francisco2 grants · $160,000
Ucsf2 grants · $155,000
Children'S Hospital of Philadelphia2 grants · $155,000
Baylor College of Medicine2 grants · $150,000

Giving over time

$1.9M

2022

$1.6M

2023

$2.4M

2024

Grant history

All 60 reported grants, largest first.

$900,000
New York Medical College · Valhalla, NY · 2022
Pediatric cancer research foundation laboratory at nymc
$550,000
New York Medical College · Valhalla, NY · 2024
Pediatric cancer research foundation laboratory at new york medical college
$550,000
New York Medical College · Valhalla, NY · 2023
Pediatric cancer research foundation laboratory at new york medical college
$275,000
New York Medical College · Valhalla, NY · 2024
Pediatric cancer research foundation laboratory at new york medical college
$204,000
V Foundation · Cary, NC · 2024
Cancer research
$150,000
Memorial Sloan Kettering · New York, NY · 2024
Towards curative epigenetic therapies of refractory pediatric sarcomas
$150,000
Memorial Sloan Kettering · New York, NY · 2023
Towards curative epigenetic therapies of refractory pediatric sarcomas
$125,000
Children'S Hospital of Philadelphia · Philadelphia, PA · 2022
Precision medicine to exploit bcl2-family survival dependencies in neuroblastoma
$125,000
University of Texas Md Anderson Cancer Center · Houston, TX · 2022
Combining a novel dendritic cell vaccine with checkpoint blockade for osteosarcoma therapy
$115,000
Stanford University · Palo Alto, CA · 2023
Targeting mitochondrial pathways in pediatric aml
$115,000
Ucsf · San Francisco, CA · 2023
Tacl2020-004: a risk stratified clinical trial for patients with newly diagnosed juvenile myelomonocytic leukemia
$115,000
University of California San Francisco · San Francisco, CA · 2022
Modulating the immune microenvironment in pediatric acute myeloid leukemia
$105,000
Dana Farber · Boston, MA · 2023
Prospective validation of a prognostic liquid biopsy approach for pediatric ewing sarcoma
$100,000
City of Hope · Duarte, CA · 2024
Single-cell dissecting of high-risk b-cell acute lymphoblastic leukemia
$100,000
Dana Farber · Boston, MA · 2024
Advancing liquid biopsies to the clinic for patients with ewing sarcoma
$100,000
Johns Hopkins · Baltimore, MD · 2024
Targeting shp2 as a therapeutic strategy in fusion-negative rhabdomyosarcoma
$100,000
Stanford · Palo Alto, CA · 2024
Targeting mitochondrial pathways in pediatric aml
$91,717
Md Anderson · Houston, TX · 2023
Combining a novel dendritic cell vaccine with checkpoint blockade for osteosarcoma therapy
$75,000
Memorial Sloan Kettering · New York, NY · 2024
Towards curative epigenetic therapies of refractory pediatric sarcomas
$75,000
Baylor College of Medicine · Houston, TX · 2023
Off-the-shelf combination cancer immunotherapy with oncolytic adeno-immunotherapy and car nk cell therapy for pediatric sarcoma
$75,000
Case Western · Clevenland, OH · 2023
Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors
$75,000
Ann & Robert Lurie Children'S Hospital · Chicago, IL · 2022
Intranasal delivery of targeting nanoliposomal therapeutics for pediatric glioma
$75,000
Baylor College of Medicine · Houston, TX · 2022
Off-the-shelf combination cancer immunotherapy with oncolytic adeno-immunotherapy and car nk cell therapy for pediatric sarcoma
$75,000
Dana-Farber Cancer Institute · Boston, MA · 2022
Prospective validation of a prognostic liquid biopsy approach for pediatric ewing sarcoma
$75,000
Stanford University · Palo Alto, CA · 2022
Development of small molecules to target cred:cbp interaction for treatment of aml
$75,000
University of Alabama at Birmingham · Birmingham, AL · 2022
Enhancement of immunovirotherapy with directed drug delivery for treatment of pediatric high-grade glioma
$74,007
University of Alabama Birmingham · Birmingham, AL · 2023
Intranasal delivery of targeting nanoliposomal therapeutics for pediatric glioma
$70,000
UCLA Foundation · Los Angeles, CA · 2023
Research into multidisciplinary approach to significantly and positively improve the quality of life of and quality of care for children and young people with cancer.
$55,000
UCLA Foundation · Los Angeles, CA · 2022
Research into multidisciplinary approach to significantly and positively improve the quality of life and quality of care for children and young people with cancer
$50,000
City of Hope · Duarte, CA · 2024
Single-cell dissecting of high-risk b-cell acute lymphoblastic leukemia
$50,000
Dana Farber · Boston, MA · 2024
Prospective validation of a prognostic liquid biopsy approach for pediatric ewing sarcoma
$50,000
Johns Hopkins University · Baltimore, MD · 2024
Targeting shp2 as a therapeutic strategy in fusion-negative rhabdomyosarcoma
$50,000
Stanford University · Palo Alto, CA · 2024
Targeting mitochondrial pathways in pediatric aml
$50,000
Hope for Henry · Washington, DC · 2023
Rewarding pediatric patients and elevating their care
$50,000
Mayo Clinic · Rochester, MN · 2023
Targeting transcriptional dependencies in atypical teratoid rhabdoid tumor
$50,000
New York University School of Medicine · New York, NY · 2023
Modulating the immune microenvironment in pediatric acute myeloid leukemia
$50,000
University of Florida · Gainesville, FL · 2023
Investigating the immune response to rna-lipid nanoparticle vaccines in a clinical trial for canines with osteosarcoma
$50,000
Hope for Henry Foundation · Washington, DC · 2022
Reinventing how hospitals care for seriously ill children and their families through innovative programs that entertain, reduce stress, and empower children to be active participants in their own care.
$50,000
Lucille Packard Children'S Hospital · Palo Alto, CA · 2022
Effective therapy for pediatric high-grade gliomas
$50,000
Texas Children'S Hospital · Houston, TX · 2022
Developing a sensitive method for cic fusion gene detection in sarcomas by customized genomic sequencing
$49,563
Hope for Henry · Washington, DC · 2024
Rewarding pediatric patients and elevating their care
$45,000
University of California San Francisco · San Francisco, CA · 2024
A risk stratified clinical trial for patients with newly diagnosed juvenile myelomonocytic leukemia
$40,000
Ucsf · San Francisco, CA · 2024
Tacl2020-004: a risk stratified clinical trial for patients with newly diagnosed juvenile myelomonocytic leukemia
$37,500
Case Western · Clevenland, OH · 2024
Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors
$37,500
Case Western · Clevenland, OH · 2024
Use of mr fingerprinting for determining response to immunotherapy in pediatric brain tumors
$37,500
Children'S Hospital Los Angeles · Los Angeles, CA · 2024
Preclinial study to translate therapy using dna hypomethylating agents for pediatric high grade gliomas
$37,500
Children'S Hospital of Los Angeles · Los Angeles, CA · 2024
Preclinial study to translate therapy using dna hypomethylating agents for pediatric high grade gliomas
$32,000
Children'S Hospital Los Angeles · Los Angeles, CA · 2024
Research into multidisciplinary approach to significantly and positively improve the quality of life of and quality of care for children and young people with cancer
$30,000
Children'S Hospital of Philadelphia · Philadelphia, PA · 2024
Elucidating how nf1 loss cooperates with setd2 to drive pediatric high-grade glioma formation
$30,000
Hope for Henry Foundation · Washington, DC · 2024
Rewarding pediatric patients and elevating their care
$30,000
Indiana University · Bloomington, IN · 2024
Decoding metabolic dependencies of mpnsts and its microenvironment
$30,000
Seattle Children'S Hospital · Seattle, WA · 2022
Development of tunable on-off car t cells for safe and durable tumor control
$29,700
Massachusetts General Hospital · Boston, MA · 2022
Optimizing car t cell immunotherapy for pediatric rhabdomyosarcoma
$27,000
Indiana University · Bloomington, IN · 2024
Decoding metabolic dependencies of mpnsts and its microenvironment
$25,000
Children'S Hospital of Los Angeles · Los Angeles, CA · 2024
Project to leverage the power of the immune system to fight pediatric high-grade glioma
$25,000
City of Hope · Duarte, CA · 2024
Reporter t cell line generation
$25,000
Ronald McDonald House Charities · Los Angeles, CA · 2024
Wildfire recovery funding for families of cancer patients at the los angeles ronald mcdonald house
$25,000
City of Hope · Duarte, CA · 2023
Reporter t cell line generation
$25,000
Ann & Robert Lurie Children'S Hospital · Chicago, IL · 2022
Immunotherapy for dipg
$8,000
Live Like Liv Foundation · Saratoga Springs, NY · 2024
Supports children and families dealing with serious conditions

Grants already paid are the record; PaperOrbit reads your paper and finds the funders whose record matches it — then explains why.

Search funders like this one

Source: IRS Form 990, Schedule I, as filed by this organization. These are grants already paid. Grants paid directly to individuals are reported to the IRS only as totals, so they do not appear as named lines here.